Sanofi wins $226m in funds to expand influenza vaccine capacity in US
Category: #headlines  By Anchal Solanki  Date: 2019-12-10
  • share
  • Twitter
  • Facebook
  • LinkedIn
Sanofi wins $226m in funds to expand influenza vaccine capacity in US
  • The agreement is supported by federal funds from BARDA
     
  • A new manufacturing unit is to be established to facilitate sustainable production

France based pharmaceutical company- Sanofi Pasteur has reportedly signed an agreement with the U.S. Department of Health and Human Services to increase the production capacity of company’s domestic pandemic influenza vaccines in Swiftwater, Pennsylvania.

The agreement is supported by federal funds received from the Biomedical Advance Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at HHS.

According to David Loew, Executive Vice President of Vaccines at Sanofi, the contract will allow the company to enhance the supply of flu vaccines under cases of pandemic influenza. Sanofi Pasteur is focusing on advancing influenza vaccine technology along with enhancing the manufacturing mechanism, the public-private partnership will furthermore help safeguard people from influenza, he added.

Apparently, the agreement will foster clinical development and manufacturing of a recombinant pandemic vaccine to prepare the world for a global pandemic situation. The investigational pandemic vaccine will use the same technology as that of Flublok® Quadrivalent – an influenza vaccine developed by Sanofi.  

Moreover, the contract will enlarge the company’s role as a leading solution for pandemic preparedness by adding both adjuvant and recombinant manufacturing along with the prevailing egg-based manufacturing technique.

For the record, Flublok Quadrivalent may be given to adults above the age of 18 and is proven to prevent more than 30% to 43% confirmed cases of the infection in people who are 50 years old and above, as compared to its alternate vaccine.

Flublok Quadrivalent is the sole and effective protein-based influenza treatment solution which is approved by the U.S. Food and Drug Administration (FDA), rendering a precise genetic match of hemagglutinin (HA) from each suggested vaccine virus. HA is primarily a protein that is key to stimulating immunity to influenza.  

Sanofi is a global biopharmaceutical firm that primarily focuses on providing support to people through their health challenges. The company aims at preventing illness with the help of vaccines, providing advanced treatment techniques to fight pain and reduce suffering.

 

Source Credits: http://www.news.sanofi.us/2019-12-09-Sanofi-awarded-226-million-by-US-government-to-expand-pandemic-influenza-preparedness

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Anchal Solanki

Anchal Solanki    

A civil engineer by qualification, Anchal Solanki forayed into the domain of content writing in the midst of her graduation, embarking on the career path of a successful freelancer. Equipped with a short-term experience in market research, Anchal currently writes news...

Read More >>

More News By Anchal Solanki

Proton to lend support to Malaysia’s Health Ministry to fight COVID-19
Proton to lend support to Malaysia’s Health Ministry to fight COVID-19
By Anchal Solanki

Amid the growing crisis caused by the coronavirus pandemic, a plethora of companies from almost every industrial sector are coming forward to make a contribution towards the global fight against COVID-19. Among those, the automotive sector is one of ...

Global Mobile Satellite Services Market: Key Strategies to Use to Dominate Globally 2020-2026
Global Mobile Satellite Services Market: Key Strategies to Use to Dominate Globally 2020-2026
By Anchal Solanki

An in-depth understanding of the Mobile Satellite Services Market has been provided in this research study. The report analyses the Mobile Satellite Services Market in terms of numerous parameters, such as growth drivers influencing the commercializa...

Global Terrestrial Trunked Radio Market: Factors Helping to Maintain Strong Position Globally 2020-2026
Global Terrestrial Trunked Radio Market: Factors Helping to Maintain Strong Position Globally 2020-2026
By Anchal Solanki

Titled ‘Global Terrestrial Trunked Radio Market Research Report’, the report is complete with an elaborate research undertaken by prominent analysts and a detailed analysis of the global industry place. The study is inclusive of a well-el...